Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$2.16B |
| 2 |
Eli Lilly
LLY
|
+$1.9B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.09B |
| 4 |
Cigna
CI
|
+$883M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$1.49B |
| 2 |
Comcast
CMCSA
|
+$1.34B |
| 3 |
Stryker
SYK
|
+$1.31B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.31B |
| 5 |
Walt Disney
DIS
|
+$1.2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.6% |
| 2 | Healthcare | 16.48% |
| 3 | Financials | 12.48% |
| 4 | Consumer Discretionary | 10.87% |
| 5 | Communication Services | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TMX
1126
DELISTED
Terminix Global Holdings, Inc.
TMX
| $38.2M | 0.01% |
1,415,238
+777,527
| +122% | +$26.5M |
|
1127
GFL Environmental
GFL
$14.9B
| $38.2M | 0.01% |
+2,467,746
| New | +$38.8M |
|
1128
Wyndham Hotels & Resorts
WH
$5.29B
| $38M | 0.01% |
1,204,998
-715,357
| -37% | -$36.4M |
|
1129
MarketAxess Holdings
MKTX
$5.72B
| $37.9M | 0.01% |
114,020
-1,622
| -1% | -$565K |
|
|
AZUL
1130
DELISTED
Azul
AZUL
| $37.9M | 0.01% |
3,719,117
-287,108
| -7% | -$9.09M |
|
1131
Travel + Leisure Co
TNL
$4.5B
| $37.8M | 0.01% |
1,743,337
-1,653,873
| -49% | -$68.9M |
|
1132
Scansource
SCSC
$1.1B
| $37.8M | 0.01% |
1,766,545
+35,000
| +2% | +$1.02M |
|
1133
Rithm Capital
RITM
$5.65B
| $37.7M | 0.01% |
7,520,468
-266,263
| -3% | -$3.86M |
|
|
GNMK
1134
DELISTED
GenMark Diagnostics, Inc
GNMK
| $37.6M | 0.01% |
9,116,380
+407,323
| +5% | +$1.91M |
|
1135
iShares MSCI ACWI ETF
ACWI
$33.3B
| $37.5M | 0.01% |
599,538
+578,785
| +2,789% | +$42.9M |
|
|
TWOU
1136
DELISTED
2U Inc
TWOU
| $37.4M | 0.01% |
58,772
-21,776
| -27% | -$14.7M |
|
|
SYRS
1137
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $37.2M | 0.01% |
627,898
+14,357
| +2% | +$974K |
|
1138
CRISPR Therapeutics
CRSP
$5.17B
| $37.2M | 0.01% |
877,014
-75,355
| -8% | -$3.89M |
|
1139
Invesco S&P 500 Pure Value ETF
RPV
$1.72B
| $37.1M | 0.01% |
927,944
+581,234
| +168% | +$34.2M |
|
1140
Varonis Systems
VRNS
$4.87B
| $36.9M | 0.01% |
1,738,428
-1,635,456
| -48% | -$42.8M |
|
|
AL
1141
DELISTED
Air Lease Corp
AL
| $36.9M | 0.01% |
1,665,423
-2,347,555
| -58% | -$89.2M |
|
|
AIMT
1142
DELISTED
Aimmune Therapeutics
AIMT
| $36.9M | 0.01% |
2,555,931
-320,352
| -11% | -$8.19M |
|
1143
Moelis & Co
MC
$4.72B
| $36.8M | 0.01% |
1,308,867
+1,118,795
| +589% | +$36.7M |
|
1144
Pultegroup
PHM
$24.8B
| $36.6M | 0.01% |
1,640,352
+879,306
| +116% | +$34M |
|
|
KSU
1145
DELISTED
Kansas City Southern
KSU
| $36.6M | 0.01% |
287,830
-665,229
| -70% | -$102M |
|
|
MFA
1146
MFA Financial
MFA
$919M
| $36.5M | 0.01% |
5,895,070
-3,563,752
| -38% | -$94.9M |
|
|
YMAB
1147
DELISTED
Y-mAbs Therapeutics
YMAB
| $36.3M | 0.01% |
1,390,842
-219
| -0% | -$6.36K |
|
1148
First Bancorp
FBP
$4.42B
| $36.3M | 0.01% |
6,818,759
-2,153,299
| -24% | -$17.7M |
|
1149
Robert Half
RHI
$4.37B
| $36.2M | 0.01% |
959,483
+654,040
| +214% | +$35.4M |
|
|
NEWR
1150
DELISTED
New Relic, Inc.
NEWR
| $36M | 0.01% |
778,103
+201,443
| +35% | +$11.8M |
|
Similar funds
Fidelity Investments's Q1 2020 Portfolio in Review
As of Q1 2020, Fidelity Investments held 4,600 positions worth $722B, down 20% from $906B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Fidelity Investments's Q1 2020 filing shows 372 new, 1,381 increased, 1,824 reduced and 431 closed positions. Its largest new stake was 1Life Healthcare: 9,509,562 shares worth $164M. The largest sale was Amgen, an estimated $1.49B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Fidelity Investments's largest Q1 2020 buy was 1Life Healthcare: 9,509,562 shares worth $164M.
- Fidelity Investments added most to Regeneron Pharmaceuticals in Q1 2020, an estimated $2.16B increase.
- Fidelity Investments's biggest Q1 2020 reduction was Amgen, cutting an estimated $1.49B.
- Fidelity Investments fully exited Taubman Centers Inc. in Q1 2020, selling an estimated $106M.
- Fidelity Investments's ten largest holdings make up 27% of its $722B portfolio in Q1 2020.
- Fidelity Investments opened 372 new positions and closed 431 in Q1 2020.
- Fidelity Investments's portfolio value fell 20% quarter-over-quarter to $722B.
Based on Fidelity Investments's 13F filing for Q1 2020, filed 14 May 2020.